131 related articles for article (PubMed ID: 25300797)
1. Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.
Yang J; Annala M; Ji P; Wang G; Zheng H; Codgell D; Du X; Fang Z; Sun B; Nykter M; Chen K; Zhang W
J Hematol Oncol; 2014 Oct; 7():76. PubMed ID: 25300797
[TBL] [Abstract][Full Text] [Related]
2. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK/37LRP/MMP2 signaling pathway in osteosarcoma.
Xing P; Liu H; Xiao W; Zhang G; Zhang C; Liao Z; Li T; Yang J
Cell Death Discov; 2024 Apr; 10(1):198. PubMed ID: 38678020
[TBL] [Abstract][Full Text] [Related]
3. Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.
Yang JL
Chin J Cancer; 2014 Dec; 33(12):575-80. PubMed ID: 25418192
[TBL] [Abstract][Full Text] [Related]
4. An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development.
Komura S; Semi K; Itakura F; Shibata H; Ohno T; Hotta A; Woltjen K; Yamamoto T; Akiyama H; Yamada Y
Stem Cell Reports; 2016 Apr; 6(4):592-606. PubMed ID: 26997645
[TBL] [Abstract][Full Text] [Related]
5. RUNX2 (6p21.1) amplification in osteosarcoma.
Gupta S; Ito T; Alex D; Vanderbilt CM; Chang JC; Islamdoust N; Zhang Y; Nafa K; Healey J; Ladanyi M; Hameed MR
Hum Pathol; 2019 Dec; 94():23-28. PubMed ID: 31669178
[TBL] [Abstract][Full Text] [Related]
6. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
7. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
8. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
9. Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway.
Saba KH; Difilippo V; Kovac M; Cornmark L; Magnusson L; Nilsson J; van den Bos H; Spierings DC; Bidgoli M; Jonson T; Sumathi VP; Brosjö O; Staaf J; Foijer F; Styring E; Nathrath M; Baumhoer D; Nord KH
J Pathol; 2024 Feb; 262(2):147-160. PubMed ID: 38010733
[TBL] [Abstract][Full Text] [Related]
10. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
Song M; Wang Y; Zhang Z; Wang S
Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
[TBL] [Abstract][Full Text] [Related]
11. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.
Zhao H; Li M; Li L; Yang X; Lan G; Zhang Y
PLoS One; 2013; 8(12):e83571. PubMed ID: 24391788
[TBL] [Abstract][Full Text] [Related]
12. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
13. DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
Wang L; Liu W; Tang H; Xie X; Zou C; Wang Y; Gao Z; Yin J
Cancer Med; 2017 May; 6(5):982-993. PubMed ID: 28374915
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27704627
[TBL] [Abstract][Full Text] [Related]
15. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
17. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9.
Jin J; Cai L; Liu ZM; Zhou XS
Asian Pac J Cancer Prev; 2013; 14(6):3681-4. PubMed ID: 23886165
[TBL] [Abstract][Full Text] [Related]
18. Roles of low-density lipoprotein receptor-related protein 1 in tumors.
Xing P; Liao Z; Ren Z; Zhao J; Song F; Wang G; Chen K; Yang J
Chin J Cancer; 2016 Jan; 35():6. PubMed ID: 26738504
[TBL] [Abstract][Full Text] [Related]
19. GDF15 promotes osteosarcoma cell migration and invasion by regulating the TGF‑β signaling pathway.
Chen G; Wang M; Liu X
Mol Med Rep; 2019 Nov; 20(5):4262-4270. PubMed ID: 31545486
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-16 suppressed the invasion and migration of osteosarcoma by directly inhibiting RAB23.
Jiao ZH; Wang JD; Wang XJ
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2598-2605. PubMed ID: 29771408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]